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www.jacctctabstracts2013.com TUESDAY, OCTOBER 29, 2013, 3:30 PM–5:30 PMimplantation, balanced with a sustained antiproliferative effect up to 12 months of
follow-up. A larger study is warranted to examine the safety of shortening the dual
antiplatelet therapy regimen on this background.
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Background: Angiographically-identiﬁed geographical miss (GM) of atherosclerotic
plaques during percutaneous coronary intervention (PCI) is common. However, the
relationship between GM and the underlying plaque as identiﬁed by virtual histology
intravascular ultrasound (VH-IVUS) as not been studied. We aimed to determine
whether GM is associated with speciﬁc plaque characteristics, PCI-related myocardial
infarction (MI4a) and future major adverse cardiovascular events (MACE).
Methods: Patients with stable angina (n¼100) or myocardial infarction (MI) (n¼70)
underwent 3-vessel VH-IVUS prior to PCI. GM was deﬁned as 3 uncovered VH-
IVUS frames in stented lesions with plaque area >40% at either stent edge. MACE
comprised death, MI, hospitalization with unstable angina or unplanned
revascularization.
Results: 30372mm VH-IVUS and 1096 lesions were analysed: 858 (78.2%) plaques
were unstented, 165 (15.1%) stented without GM, and 80 (7.3%) stented with GM.
GM was associated with increased plaque volume, necrotic core %, dense calcium %
and VH-deﬁned thin cap ﬁbroatheroma (VHTCFA) and with reduced ﬁbrous tissue %
(table). GM was not associated with increased MI4a (33 (54%) vs. 71 (72%), p¼0.15)
or inﬂammatory cytokine release. MACE (n¼43) occurred in 28 patients over
a median follow-up of 1115 [968-1537] days. MACE were directly linked to 11/858
(0.8%) unstented plaques, 7/165 (4.2%) fully covered stented lesions and 8/80 (10%)
stented lesions with GM (log rank p<0.001). In patients presenting with MI, stented
lesions with GM had increased future MACE compared to fully covered lesions (log
rank p¼0.015).Plaque parameters
Completely
covered plaques Geographical miss p value
(n=165) (n=80)
Plaque Burden
70% (n (%))
110 (67%) 62 (78%) 0.058
Minimum luminal
area 4mm2
(n (%))
126 (76%) 54 (68%) 0.18
Remodeling index 1.03 [0.91-1.14] 1.00 [0.91-1.19 0.9
Segment length
(mm)
17 [8-29] 32 [19-51] <0.001
Plaque volume
(mm3)
122 [53-216] 271 [131-443] <0.001
Fibrous tissue (%) 59 [51-66] 55 [48-61] 0.001
Necrotic core (%) 20 [15-26] 25 [18-29] 0.001
Dense calcium (%) 7 [3-12] 10 [6-16] <0.001
VH-IVUS
pathological
intimal thickening
(n (%))
17 (10%) 1 (1%) 0.011
VH-IVUS
ﬁbrocalciﬁc plaque
(n (%))
8 (5%) 5 (6%) 0.65
VH-IVUS thick-
capped
ﬁbroatheroma
(n (%))
17 (10%) 7 (9%) 0.4
VH-IVUS thin-
capped
ﬁbroatheroma
(VHTCFA) (n (%))
111 (67%) 66 (83%) 0.013
Non-calciﬁed
VHTCFA (n (%))
35 (21%) 10 (13%) 0.095
Calciﬁed VHTCFA
(n (%))
80 (48%) 55 (69%) 0.003
JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT Abstr
P
O
S
T
E
R
SConclusions: GM is associated with larger plaques with a more vulnerable compo-
sition and type and with future MACE in MI patients undergoing PCI. Whether the
association of GM with future MACE is independent of adverse plaque anatomy is not
clear and requires a much larger study to determine.
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Background: Implantation of drug-eluting stents (DES) in patients with ST-segment
elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary
intervention (PCI) reduces in-stent restenosis compared with bare metal stents (BMS),
however, the long-term risk of DES use in STEMI has been pointed. Previous patho-
logical and optical coherence tomography (OCT) study reported that ﬁrst generation
DES use in STEMI resulted in higher rates of uncovered and malapposed stent struts at
follow-up. The long-term safety of second generation everolimus-eluting stents (EES)
use in STEMI remains unknown. We used OCT to examine vascular response including
strut coverage and malapposition in patients with STEMI treated with EES and BMS.
Methods: We enrolled 85 patients with STEMI who underwent primary stenting and
10-month follow-up OCT (EES: 47 patients and BMS 38 patients).
Results: A total of 18244 stent struts were analyzed. There were no signiﬁcant
differences in the percentage of uncovered and malapposed stent struts per lesion
between 2 stents (2.283.08% versus 1.472.46%, P¼0.182 and 0.571.22% versus
0.410.84%,P¼0.499, respectively). Averaged neointimal thickness was smaller in
EES lesions (103  38 mm vs. 385  151 mm, P<0.001). Intra-stent thrombus was
observed in 12.8% of EES lesions and 10.5% of BMS lesions (p ¼ 0.750).
Conclusions: In STEMI patients undergoing primary PCI, there are no signiﬁcant
differences in the percentage of uncovered and malapposed stent struts, and the
incidence of intra-stent thrombus at 10-month follow-up between EES and BMS. On
the other hands, EES as compared with BMS signiﬁcantly reduces neointimal
hyperplasia. EES has a potential to achieve low late loss without sacriﬁcing safety.
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Background: Slow ﬂow or no re-ﬂow phenomenon during coronary intervention is
mainly caused by distal embolization of thrombus and plaque debris, and is associated
with unfavorable long-term clinical outcomes. This phenomenon often occurs in the
patients with acute coronary syndrome (ACS) but also in some patients with stable
angina. However, the high-risk patients of distal embolization are not well understood.
Methods: Consecutive patients with acute myocardial infarction (AMI) (n¼192),
those with unstable angina (UA) (n¼89), and those with stable coronary heart disease
(CHD) (n¼211) who received coronary intervention with ﬁlter-type distal protection
device (Filtrap) were prospectively enrolled. We compared between the groups the
frequency of ﬁlter slow ﬂow/ no-reﬂow phenomenon and of distal embolization
captured by the ﬁlter device. We examined by angioscopy if ruptured plaque was
present at the target lesion and analyzed its association with ﬁlter slow ﬂow/ no
re-ﬂow phenomenon or distal embolization.
Results: Filter slow ﬂow/ no re-ﬂow phenomenon occurred most frequently in AMI
patients, although there was no difference between UA and CHD patients (43% vs.
20% vs. 18%, P<0.001). Filter slow ﬂow/ no re-ﬂow phenomenon occurred more
frequently in the patients with vs. without ruptured plaque in each patient group (AMI
patients: 79% vs. 8%, P<0.001; UA patients: 57% vs. 7%, P¼0.001; CHD patients:
72% vs. 6%, P<0.001). Among the patients without ruptured plaque, the incidence
was not different between the patient groups.
Conclusions: Although AMI patients are at high risk of ﬁlter slow ﬂow/ no re-ﬂow
phenomenon and of distal embolization than UA or CHD patients, the risk was
associated with the presence of ruptured plaque. Patients with ruptured plaque had the
higher risk than those without it regardless of the diagnosis.
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Background: Signiﬁcant plaque shift during stenting can result in side branch
compromise in certain cases. This study aimed to evaluate potential effects ofacts/POSTER/Intravascular Imaging and PCI B171
